ABVC BioPharma
ABVC
ABVC
9 hedge funds and large institutions have $79.8K invested in ABVC BioPharma in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
74% less capital invested
Capital invested by funds: $304K → $79.8K (-$224K)
Holders
9
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$21K | |
| 2 | +$16.2K | |
| 3 | +$5.77K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.66K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$5 |
Top Sellers
| 1 | -$21.2K | |
| 2 | -$11.5K | |
| 3 | -$9.57K | |
| 4 |
BlackRock
New York
|
-$3.02K |